Notably, JQ1, a BRD4 inhibitor, was shown to inhibit the SHH-mediated proliferation of several tumors, including medulloblastomas, and to overcome their resistance to SMO antagonists [82]. The gene discussed is BRD4; the disease is medulloblastoma.